Corriente Advisors

Latest statistics and disclosures from Corriente Advisors's latest quarterly 13F-HR filing:

Portfolio Holdings for Corriente Advisors

Companies in the Corriente Advisors portfolio as of the March 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Reata Pharmaceuticals Inc Cl A stock 29.60 190000 144.34
Maxar Technologies Inc 19.47 1.69M -37% 10.68
Aptose Biosciences 18.71 2.92M +544% 5.94
Cue Biopharma Inc 12.56 820000 +187% 14.19
Grayscale Bitcoin Ord 4.53 590000 NEW 7.12
Pieris Pharmaceuticals 4.39 1.78M NEW 2.28
Epizyme 3.85 230000 NEW 15.51
Schrodinger Inc Com stock 2.79 60000 NEW 43.12
Bellus Health Inc New 1.60 148666 -32% 9.98
Sunesis Pharmaceuticals Inc Ne 1.35 3.02M NEW 0.41
Tesla Motors (TSLA) 1.13 2000 NEW 524.00

Past Filings by Corriente Advisors

View past SEC 13F filings by Corriente Advisors

View all filings